KALA KALA BIO, Inc.
$0.18▼ -5.59%
Healthcare
Other
After hours
$0.19▲ +5.23%
Oct 27, 5:52 PM ET
Volume 188.4K
Avg Volume (10D) 454.7K
Key Metrics & Fundamentals
Market Cap
$3.40M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.12 - 95.50
% vs 50 MA
-63.58%
% vs 200 MA
-97.58%
RSI-14
20.6
MACD Histogram
+0.0100
Beta (1Y vs SPY)
2.56
Free Cash Flow
-$1.54M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.58M
COGS
–
Operating Exp
$1.72M
Operating Income
-$1.72M
EBIT
-$1.72M
Pretax Income
-$1.58M
Net Income
-$1.58M
EPS (Diluted)
-21.32
Price & Volume History
Loading chart…
Recent News
KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform with Approximately $48 Million in Sales Since Inception
TMX Newsfile · Sep 29, 2026 7:30 AM ET
Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products
GlobeNewswire · Sep 24, 2026 7:30 AM ET
KALA BIO Adds Healthcare Operator Yenvy Truong to Advisory Team
GlobeNewswire · Sep 17, 2026 7:30 AM ET
Kala Bio Signs Exclusive U.S. Distribution Agreement for Virotek Ophthalmology Genetic Tests
InvestorsHub · Sep 3, 2026 9:47 AM ET
Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
GlobeNewswire · Sep 3, 2026 8:30 AM ET
Kala Bio Targets Near-Term Revenue With Virotek Ophthalmology Genetic Testing Partnership
InvestorsHub · Sep 1, 2026 11:05 AM ET
Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
GlobeNewswire · Sep 1, 2026 7:45 AM ET
KALA BIO: Q2 Earnings Snapshot
Associated Press · Aug 19, 2026 4:32 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See KALA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.